Company: IMCR
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012123
Chunk: 125

Company: Immunocore Holdings plc
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 125
---
 2021, and we do not have any historical remuneration to disclose for periods prior to 2021.

| Year |     | Method |     |       CEO |     | 25thpercentile pay |     |       |     | Median pay |     |       |     | 75thpercentile pay |     |      |
|:-----|:----|:-------|:----|----------:|:----|-------------------:|:----|:------|:----|-----------:|:----|:------|:----|-------------------:|:----|:-----|
| $    |     | $      |     |     Ratio |     |                  $ |     | Ratio |     |          $ |     | Ratio |     |                    |     |      |
| 2024 |     | B      |     | 1,474,165 |     |             55,547 |     | 27:1  |     |     74,095 |     | 20:1  |     |            123,820 |     | 12:1 |
| 2023 |     | B      |     | 1,403,204 |     |             54,944 |     | 26:1  |     |     72,637 |     | 19:1  |     |            105,236 |     | 13:1 |
| 2022 |     | B      |     | 1,417,606 |     |             46,868 |     | 30:1  |     |     67,368 |     | 21:1  |     |            120,732 |     | 12:1 |
| 2021 |     | B      |     | 1,270,414 |     |             56,939 |     | 22:1  |     |     70,025 |     | 18:1  |     |            132,040 |     | 10:1 |

The remuneration for employees in the UK workforce is based on the data used for gender pay reporting, which comprises salary and benefits as of 5 April of each applicable year and incentive payments payable in respect of the full years ended 31 December of each applicable year. Actual benefit amounts are used for the purposes of ratio in the table above. The ratios have been calculated using Method B as we believe it provides the